Wilson disease is an autosomal recessive disorder characterised by toxic accumulation of copper in liver, brain and other organs. The disorder is caused by mutations in the ATP7B gene, encoding a copper transporting P-type ATPase. Based on the number of known patients with this diagnosis in Sweden, the prevalence can be estimated to 1 in 250 000 to 300 000, whereas the prevalence of Wilson disease has been estimated to be 1 in 30 000 in other populations. We estimated the prevalence of 
Introduction
Wilson disease is an autosomal recessive disorder characterised by failure to incorporate copper into ceruloplasmin in the liver and to excrete copper from the liver to the bile, resulting in toxic copper accumulation predominantly in liver and brain. 1, 2 This results in acute and chronic liver disease and/or neurologic dysfunction. Diagnosis of Wilson disease is based on lowered levels of ceruloplasmin and increased free copper levels in urine and serum as well as on elevated copper concentrations in the liver. Wilson disease is lethal if left untreated, but if diagnosed, progression of the disease can be interrupted. However, as the typical biochemical findings may also be observed in other hepatic disorders, Wilson disease can sometimes be difficult to diagnose. Furthermore, some patients neither show clinical signs of neurologic dysfunction nor do they have the typical corneal deposits of copper, the so-called Kayser-Fleischer rings. 3 The gene causing Wilson disease was cloned in 1993 [4] [5] [6] and named ATP7B. The protein encoded by this gene is a copper transporting P-type ATPase, which is predominantly expressed in liver and brain. 7 Almost 200 mutations in the ATP7B gene have been reported world wide (http:// www.medgen.med.ualberta.ca/database.html). The two most common mutations in Swedish patients are a C-A transversion in exon 14 (C3207A) and a C-T transition in exon 13 (C2930T), accounting for 33% and 11% of the Swedish disease alleles, respectively. 8 The prevalence of Wilson disease in Sweden has been estimated to be 1 in 250 000, whereas its prevalence has been estimated to be 1 in 30 000 in other populations. 9 In the present study we determined the frequency of the two major disease-causing alleles in the ATP7B gene in a large Swedish population sample to investigate if the 10-fold lower prevalence of Wilson disease could be due to patients being missed in the clinic. In order to simplify detection of rare disease alleles we used a strategy in which pools of 10 DNA samples were analysed for the presence of the two major disease-causing mutations in Sweden. The ATP7B gene also contains several singlenucleotide polymorphisms (SNPs) that are more common in the population than the disease-causing mutations. 8, 10 To determine the Swedish allele frequencies of eight of the common SNPs in coding regions of the ATP7B gene in the same sample material, we devised a different pooling strategy. A large pool, consisting of 2500 Swedish DNA samples, was analysed quantitatively to determine the proportion of the two sequence variants of each SNP, which reflects directly the allele frequencies at these sites in the Swedish population. In both strategies the pooled DNA samples were analysed by the solid phase minisequencing method. 11 This PCR-based primer extension method identifies single nucleotide variations by incorporation of a single labelled nucleotide analogue. The analysis showed that the minisequencing method allows sensitive detection of minority sequence variants and accurate quantitative analysis of sequence variants present as a mixture in a pooled DNA sample.
Material and methods

DNA samples
DNA was extracted from 2640 anonymous Swedish blood samples. DNA was extracted from the blood samples using the Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA). The DNA concentration of the samples was determined by measuring the absorbance at 260 nm in a spectrophotometer (DU 530 Beckman Instruments Inc, Fullerton, CA, USA). First, equal amounts of DNA from 10 individuals were combined into pools with DNA concentrations of 200-400 ng/µl. These pools of 10 samples were further combined into a large 'super pool' containing an equal amount of DNA from 2500 individuals. The rare alleles were detected in pools of 10 samples and the frequencies of common SNP alleles were determined from the 'super pool'.
PCR amplification
The PCR primers were designed using the OLIGO program (Molecular Biology Insights Inc, Cascade, CO, USA) based on unpublished intronic sequences of the ATP7B gene, kindly provided by Drs Conrad Gilliam and Konstantin Petrukhin (Columbia University, New York). The sequence of the 5'-biotinylated forward primer for exon 13 was 5'-ACT CTG TCC TGT TTT CAG AAC CC-3' and that of the reverse primer was 5'-CGT GCT ACA GGC TGA CCT TGT GC-3'. The forward 5'-biotinylated primer for exon 14 was 5'-AGA CTG TGA TGT TTG ACA AGA CTG G-3' and the reverse primer was 5'-CCA AGT CCA CGT ACC TCT TTA-3'. The sequences of the primers for amplifying the exons containing eight SNPs in the ATP7B gene are given in Waldenström et al. 8 The (Table 1 ). The plates were incubated at 50°C for 10 min. The unincorporated label was removed by washing as above, and the detection primers were released with 100 µl of 0.1 M NaOH, and measured in a liquid scintillation counter (1414, Wallac, Turku, Finland). Interpretation of the result The result of the minisequencing assay is expressed as the ratio between the signals from the incorporated [ 3 H]-dNTP corresponding to the two sequence variants at each analysed site. A DNA sample with a 1:20 ratio between the mutant and normal sequence (5%) was included in each series of pools as a reference sample for identification of DNA pools containing one mutant allele among the 20 alleles in each pool. The presence of a rare mutant allele in a pooled DNA sample is revealed by a signal ratio that is in the same range as that of the 5% reference sample, and elevated by more than two standard deviations compared with the ratio in a homozygous normal sample with 0% of the mutant allele. The allele frequencies (f) of the common SNPs were calculated by comparing the signal ratios observed in the large pooled sample (R pool ) to the corresponding signal ratios in heterozygous samples (R Het ), where the two alleles are present at a 1:1 ratio (50%) according to the formulae:
Results
In the present study we determined the Swedish population frequencies of the two major mutant alleles of the ATP7B gene which cause the recessively inherited Wilson disease, and the population frequencies of eight common single polymorphisms (SNPs) in the ATP7B gene. The allele frequencies of both the rare alleles due to mutations in exon 13 and 14 of the ATP7B gene and those of the eight more common SNPs were determined by analysing pooled DNA samples quantitatively by competitive PCR using the solidphase minisequencing method. Two different pooling strategies were employed.
Detecting rare alleles
To estimate the optimal pool size for detecting rare Wilson disease-causing alleles, two standard curves were constructed by analysing samples containing mixtures of known amounts of the mutant and normal sequence in exons 13 and 14 ( Figure 1 ). As can be seen from the standard curve in Figure 1A , samples containing significantly less than 1.5% of the sequence with a mutation in exon 13 can be distinguished from a homozygous normal sample (with 0% of the mutant sequence). The sensitivity of detecting the mutation in exon 14 of the ATP7B gene was about 3% ( Figure 1B ). For both mutations there is a linear relationship between the ratio of the two sequence variants in the sample and that of the labelled allele-specific nucleotides incorporated in the minisequencing reactions from the detection limit up to at least 50% of the mutant sequence. Based on the observed sensitivity, equal amounts of DNA were pooled from sets of 10 samples to allow for errors in the DNA quantification, although the sensitivity determined from the standard curves would have allowed larger pools. With this pool size the mutant sequence would constitute 5% in pools including a single carrier individual. Altogether 264 pools were analysed Table 2 ). An elevated signal ratio in pool 158 (Table 2) indicated that it contained one heterozygous sample with the exon 13 mutation of the ATP7B gene. The individual DNA samples in pools showing elevated signal ratios were analysed individually, and a heterozygous carrier of the Wilson disease mutation was identified in each of them. Based on this analysis, the Swedish population frequency of the mutant allele in exon 14 is expected to be 1/1300 with a 95% confidence interval between 1/560 and 1/4400. The frequency of the exon 13 mutation is 1/5300 with a wide 95% confidence interval of between 1/1200 and 1/100 000. The frequencies of the exon 14 and 13 mutations estimated from the number of patients and the proportion of these mutations among the patients in Sweden are 1/760 and 1/2300, respectively.
Detecting common alleles or SNPs
The coding sequence of the ATP7B gene contains eight common SNPs of which three are silent, and five are missense changes. 8 The frequencies of these sequence variants were determined rapidly and accurately using a different pooling strategy. An equal amount of DNA from 2500 individuals out of the 2640 analysed was combined into a 'super pool', which was subjected to quantitative analysis by the minisequencing method for each of the eight SNP sites. The ratios of the sequence variants in the super pool, corresponding to their population frequencies, were estimated from the ratio between the 3 H-labeled dNTPs incorporated in the minisequencing reactions. The minisequencing ratio is influenced if the sequence immediately downstream of the analysed nucleotide position contains more than one of the same nucleotide, so that more than one 3 H-labeled dNTP is incorporated for this allelic variant. That is the case for the G2495A and C3419T polymorphisms (Table 3 ). In practice, the ratio is also affected by any sequence dependent misincorporation of 3 H-labeled dNTPs by the DNA polymerase that may occur. To correct for these sequence contextdependent factors, heterozygous samples, in which the two alleles are known to be present in equal amounts, were used as quantification standards for each of the analysed SNPs (Table 3 ). The allele frequencies of the SNPs were also determined by genotyping 20 individual DNA samples at each SNP. This analysis gave a result concordant with the quantitative analysis of the 'super pool'. Table 3 shows the Swedish allele frequencies of the eight SNPs.
Discussion
We applied two different pooling strategies for rapid and accurate determination of the Swedish population frequencies of ten sequence variants in the ATP7B gene. The frequencies of the two most common mutant alleles of the ATP7B gene causing Wilson disease in Sweden 8 were determined by analysis of pooled samples, each of which contained an equal amount of DNA from 10 individuals. The number of identified carriers of these two ATP7B gene mutations coincides with the expected carrier frequency based on the number of diagnosed patients with Wilson disease and on the distribution of the exon 13 and 14 mutations among these patients. 8 Our study supports the view that Wilson disease is well diagnosed in Sweden, and that the disease is really more rare in Sweden than in other countries, although the number of identified carriers was small. A pooling approach has been proposed previously for population screening of the cystic fibrosis three base pair deletion mutation ∆F508 by PCR-based heteroduplex analysis. A model for calculating the most cost-effective number of samples to be pooled based on the population frequency of the mutation to be detected was also presented. 12 For rare mutant alleles, such as the Wilson disease alleles, the optimal number of samples per pool is in practice determined by the sensitivity of the method applied for detecting the minority allelic variant in an excess of the normal sequence. For hybridisation and sequencing methods the detection limit for genomic sequence variants is 10% or higher. [13] [14] [15] The minisequencing method has proved to be more sensitive, as illustrated in a previous study, in which we were able to detect a rare recessive disease allele at the 1% level in pooled DNA samples. 16 In detecting the two Wilson disease alleles, the detection limit of the minisequencing method was lower than 1% to 3%, respectively. Based on our experience with mean signal ratio in pools that were interpreted as negative for the analysed mutation and a reference sample with 5% of the mutant sequence in the same experiment.
Allelic variants of the ATP7B gene y C Olsson et alother mutations the detection limit is in most cases close to 1% when 3 H-dNTPs are used as label, but higher with other labelled nucleotide analogues. 17 Currently there is much effort to discover dense sets of SNPs to serve as markers to identify genes underlying common, multifactorial disorders by genome-wide linkage disequilibrium mapping or analysis of candidate genes. In the year 2000 SNP consortium has catalogued 300 000 SNPs. 18 Once the SNPs have been discovered, population-specific allele frequency databases will need to be established for them. To create allele frequency databases and perform association studies, a significant increase in throughput and reduction in costs of the current available assays for typing SNPs is needed. One means would be to analyse alleles quantitatively in pooled DNA samples containing DNA from a large number of case and control individuals instead of genotyping individual DNA samples. The concept of DNA sample pooling to reduce labour and costs in an association study was first suggested in 1985 by Arnheim et al. 19 In that study Southern blot hybridisation was used to search for restriction fragment length polymorphisms in the HLA class II locus that were in linkage disequilibrium with susceptibility to insulin-dependent diabetes in pooled samples containing DNA from tens of individuals. In several subsequent studies allele frequencies of microsatellite markers were determined by analysis of pooled DNA samples using PCR, followed by size separation and quantification of alleles. [20] [21] [22] We earlier determined quantitatively the allele frequencies of a panel of SNPs to be used in forensics in large pooled samples containing DNA from several hundred individuals by competitive PCR using solid-phase minisequencing. 11 In the present study the method proved accurate for quantification of eight common variant alleles in the ATP7B gene in a large 'super pool' of 2500 individuals. We conclude that minisequencing primer extension is a suitable reaction principle for future cost-effective population-based screening of rare mutations, for determination of The nucleotides denoted as 'normal' are those given in the published sequence of the ATP7B gene (accession no. U03464, GenBank); the normal nucleotide is given on the left, followed by the nucleotide number in the ATP7B sequence; a mean value and standard deviations of four parallel assays from the same PCR product; b calculated using a 5% allele mixture as reference.
Allelic variants of the ATP7B gene C Olsson et al y population frequencies of SNPs and for association studies using pooled samples on a large scale.
